Latest News
These healthcare leaders can make you money while you sleep.
Via The Motley Fool · December 2, 2025
Via MarketBeat · December 2, 2025
These stocks look poised to outperform the S&P 500 over the long run.
Via The Motley Fool · December 2, 2025
The company's finally got some credible competition, with more waiting in the wings.
Via The Motley Fool · December 2, 2025
Why Did CTRN Stock Gain Nearly 10% In Premarket Today?stocktwits.com
Via Stocktwits · December 2, 2025
The quantum computing company has rewarded early investors.
Via The Motley Fool · December 2, 2025
Shiba Inu has bitten off more than it can chew.
Via The Motley Fool · December 2, 2025
Dividend Kings are companies that have paid and raised their dividends for at least 50 years.
Via The Motley Fool · December 2, 2025
Oracle stock is coming off a brutal month, with shares sliding more than 20% in November and starting December with a loss.
Via Investor's Business Daily · December 2, 2025
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.
Via Investor's Business Daily · December 2, 2025
The EUR/USD pair retreated to 1.1612 on Tuesday, pulling back from a recent two-week high.
Via Talk Markets · December 2, 2025
There's still time to get in on these rising stars.
Via The Motley Fool · December 2, 2025
Third-quarter results and fourth-quarter guidance have reinforced confidence in MongoDB’s potential in the AI-driven software market.
Via Stocktwits · December 2, 2025
McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation, backed by solid profitability and financial strength.
Via Chartmill · December 2, 2025
The Reserve Bank of Australia’s final interest rate call of the year is coming up.
Via Talk Markets · December 2, 2025
Discover why Applied Digital may be one of the most surprising AI infrastructure growth opportunities heading into 2026.
Via The Motley Fool · December 2, 2025
Mueller Industries (MLI) combines strong fundamentals like zero debt and high profitability with positive technical momentum and market-beating performance.
Via Chartmill · December 2, 2025
Headline inflation increased from 2.1 to 2.2% in November, while core inflation remained stable at 2.4%.
Via Talk Markets · December 2, 2025
The company is trying to get back on track after a tumultuous year.
Via The Motley Fool · December 2, 2025
Make sure to check these off your list by Dec. 31.
Via The Motley Fool · December 2, 2025
In a filing with the Securities and Exchange Commission, YZi Labs argued the current board has underperformed and failed to act in shareholders’ best interests.
Via Stocktwits · December 2, 2025
Drilling down into Chevron's returns.
Via The Motley Fool · December 2, 2025
Cybersecurity has become the goldmine of software infrastructure, as escalating risk events push companies to spend without hesitation.
Via Stocktwits · December 2, 2025
Veracyte (VCYT) exemplifies GARP investing with strong cancer diagnostic growth, reasonable valuation vs. biotech peers, and a debt-free financial foundation.
Via Chartmill · December 2, 2025
The Pound Sterling faces pressure against its major currency peers amid dovish BoE expectations.
Via Talk Markets · December 2, 2025